Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11919934 IL-15 conjugates and uses thereof

Patent 11919934 was granted and assigned to Synthorx on March, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Carolina E. Caffaro0

Marcos Milla0

Jerod Ptacin0

Date of Patent

March 5, 2024

0

Patent Application Number

170019650

Date Filed

August 25, 2020

0

Patent Citations

US Patent 7858081 IL-15 mutants having agonists/antagonists activity

0

US Patent 8501805 Substituted alpha-L-bicyclic nucleosides

0

US Patent 8546556 Carbocyclic alpha-L-bicyclic nucleic acid analogs

0

US Patent 8778631 Mono charging system for selectively introducing non-native amino acids into proteins using an in vitro protein synthesis system

0

US Patent 9089614 Hydrophilic self-immolative linkers and conjugates thereof

0

US Patent 9328159 Multimeric IL-15 soluble fusion molecules and methods of using same

0

US Patent 9682934 Modified amino acids

0

US Patent 9840493 Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use

0

...

Patent Primary Examiner

0

CPC Code

0

Patent abstract

Disclosed herein are interleukin (IL) 15 conjugates and use in the treatment of one or more indications. Also described herein include pharmaceutical compositions and kits comprising one or more of IL-15 conjugates.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11919934 IL-15 conjugates and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool